APIMEDS PHARMACEUTICALS US, INC. Proceeds from Issuance of Debt
APIMEDS PHARMACEUTICALS US, INC. (APUS) reported Proceeds from Issuance of Debt of $3.00 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2025-11-12
- APIMEDS PHARMACEUTICALS US, INC. proceeds from issuance of debt for the quarter ending 2025-09-30 was $0.00.
- APIMEDS PHARMACEUTICALS US, INC. proceeds from issuance of debt for fiscal 2024 was $3.00M.
| Period end | Proceeds from Issuance of Debt | Proceeds from Issuance of Debt 3 month | Proceeds from Issuance of Debt 6 month | Proceeds from Issuance of Debt 9 month | Proceeds from Issuance of Debt 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $3.00M 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | $3.00M 10-Q · filed 2025-08-19 | ||||
| 2024-12-31 | $3.00M 10-K · filed 2025-04-15 | ||||
| 2024-08-19 | $3.00M 10-Q · filed 2025-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |